Exparel 266 MG/20 ML vial 20ML
Ended Awarded
- Contract number
- SPE2DB25FZX88
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,043
Award facts
- Contract value 100% obligated
- $10,042.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $10,042.52 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 266 mg/20 mL vials of Exparel. The contract, issued on September 9, 2025, with an ultimate completion date of September 30, 2025, carries no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at $499,999,999 through November 2026, which authorizes the agency to procure a comprehensive range of pharmaceutical products and medical supplies supporting Department of Defense healthcare facilities worldwide.
Exparel is a liposomal bupivacaine formulation used for infiltration and nerve block anesthesia in surgical settings. DMS Pharmaceutical Group has established itself as a critical supplier in the federal pharmaceutical supply chain, consistently delivering branded and generic prescription drugs, biologics, and medical consumables to military healthcare systems. The company's extensive contract portfolio with DLA demonstrates its reliable capacity to fulfill federal medical supply requirements across diverse product categories, positioning it as a key vendor for defense healthcare logistics.
Quick answers
Who was awarded contract SPE2DB25FZX88?
SPE2DB25FZX88 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 9, 2025.
How much is contract SPE2DB25FZX88 worth?
The government has obligated $10,043 on SPE2DB25FZX88.
Is contract SPE2DB25FZX88 an order under another contract?
Yes. SPE2DB25FZX88 is a delivery order under SPE2DB20D9135, an indefinite delivery contract.
Was contract SPE2DB25FZX88 competed?
The extent of competition for SPE2DB25FZX88 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award